|
|
|
09161
|
|
|
P.I.:
|
George Somlo, MD
|
(Institutional)
|
|
Title:
|
Role of Stat3 in Human Breast Cancer as a Target of Cancer Therapy
|
|
|
09147
|
|
|
P.I.:
|
George Somlo, MD
|
(Institutional)
|
|
Title:
|
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoaduvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
|
|
|
09125
|
|
|
P.I.:
|
George Somlo, MD
|
(Industrial)
|
|
Title:
|
A Randomized, Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzumab-MCC-DM1 VS. Capecitabine + Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab-Based Therapy
|
| | |
|
|
09106
|
|
|
P.I.:
|
George Somlo, MD
|
(Cooperative Group)
|
|
Title:
|
CALGB 40603: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
|
| | |
|
|
09091
|
|
|
P.I.:
|
George Somlo, MD
|
(Industrial)
|
|
Title:
|
An Open Label, Single Arm, Phase 2 Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
|
| | |
|